1.A study on genetic polymorphism and rare alleles of 15 STR loci in 10071 individuals in Guangdong Han population
Haiyan LI ; Yunchun TAI ; Huiling LU
Chinese Journal of Forensic Medicine 2002;0(06):-
Objective To study the genetic polymorphism and frequencies of 15 STR loci in 10071 unrelated individuals of Han nationality, which are compared with the data reported previously. Methods 15 STR loci were amplified in DNA samples from 10071 unrelated individuals in Guangdong Han population using PowerPlex~(TM) 16 system, which were genotyped with ABI 377 or 3100 Genetic Analyzer. Frequencies for 15 STR loci were obtained. Results Except D8S1179 locus, rare alleles were found in the other 14 STR loci. The number of rare alleles ranged froml to 7 in the 14 STR loci ,which increased up to 34 rare alleles, including D21 S11 (32.1 and 36.2), D18S51 (15.2 and 17.2), Penta E (15.2, 17.4, 18.4, 19.4, 26 and 27), D7S820 (9.2, 10.1, 11.1 and 15), Penta D (18, 19 and 20), TPOX (14) and FGA (13) which were detected the first time and D21S11 (30.3), D7S820(9.1 and 9.2) which were frequently seen in the population although infrequent in European population. Conclusion More rare alleles can be detected with genetic polymorphism data from a lager number of individuals and more credible frequencies of alleles be obtained.
2.Study on apoptosis of the HCT116 cells mediated by cisplatin and its mechanisms
Yunchun LI ; Li ZHONG ; Xiuying TANG ; Tao MA
Clinical Medicine of China 2009;25(10):1076-1079
Objective To study the apoptosis mediated by cisplatin on human colorectal tumors (HCT116) cell line and its mechanisms in vitro. Methods The apoptosis levels of HCT116 cells mediated by cisplatin at vari-ous time and in different concentration were measured by M30-ApoptosisTM -ELISA-kits and flow cytometry assay. The expressions of the protein p53,p21 and Bcl-2 were assessed through Western-Blotting. Results Cisplatin in-hibited the proliferation in a time-and dose -dependant manner ( F = 1129. 383, P = 0. 000 and F = 125. 267, P = 0. 000, respectively). The sub-G1 peak detected by flow cytometry at 24,48,72 hours of the apoptosis rates showed a significant difference between the experimental group and the control group (χ2= 5. 669,14.110,12. 221, P = 0. 010,0.003,0. 000,respectively). We found significant differences on the HCT116 cell growth between different time under cisplatin effect (χ2 = 14.008 ,P =0. 003 ). There were significant difference on the CK18-Asp237-Asp396 re-leased by HCT116 cell between different casplatin concentration (F =48. 667 ,P =0.000) as well as different times ( F = 1194. 394, P = 0.000). The Western-Blotting results indicated that the expression level of the p53 ( t = 9.873, -2.906,7. 229,2.776,P =0.000,0. 007,0. 000,0. 011 ) and p21 (t = - 10. 692, - 8. 867, - 15. 063, - 16.281, P = 0. 000,0.001,0.000,0.000 ,respectively) increased gradually, while there are no effect on the expression of the protein Bcl-2(t=1.429,2.011,2.247,2.001,P=0. 178,0.069,0.053,0.062,respectively). Conclusions Cis-platin can induce the apoptosis on HCT116 cells and thus inhibit the reproduction of tumor cells by recovering the function of p.53.
3.Application of 13 High-risk HPV infection Test Combined with Thinprep Cytologic Test on Screening Cervical Carcinoma in Dali Region, Yunnan Province
Zhengjin LI ; Xitong YANG ; Lei BI ; Yunchun LIU ; Shiyun ZHANG
Journal of Kunming Medical University 2016;37(7):26-29
Objective To investigate relativity between the epidemiology of HPV and cervical carcinoma in Dali region,Yunnan province,through detecting the 13 high-risk human papillomavirus infection and Thinprep cytologic test in 2153 cases.Methods Real-time PCR was used to detect the 13 high-risk HPV (16,18,31,33,35,39,45,51,52,56,58,59,68) in2153 cases and 1604 cases were checked with Thinprep cytologic test.Results In 2153 samples,260 cases were infected with HPV,with the positive rate of 12.08%.The highest positive rates were >60 years old (18.18%),then >20 and ≤30 years old (14.41%);there was no significant difference in the positive rate among the various age groups (P =0.384).There were 1465 negative for intraepithelial lesion ormalignancy (NILM) cases (91.33%),86 atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells cannot exclude HSIL (ASC-H) cases (5.36%),32 low-grade squamous intraepithelial lesion cases (LSIL) cases (2.00%),21 high-grade squamous intraepithelial lesion cases (1.31%) through Thinprep cytologic test.The correlation coefficient is 0.893.Conclusions The infection rate of HPV in Dali region,Yunnan Province,has no significant difference among the various age groups.Application of 13 high-risk HPV infection test combined with Thinprep cytologic test could be more effective in screening cervical carcinoma.
4.Study on permeability of brain derived neurotrophic factor through placental barrier and fetal blood brain barrier after transient uteroplacental ischemia
Dan YU ; Meng MAO ; Yunchun LI ; Hui ZHOU ; Sufei YANG ;
Chinese Journal of Perinatal Medicine 2003;0(06):-
Objective To investigate whether exogenic brain derived neurotrophic factor (BDNF) can permeate placental barrier into fetus and further through fetal blood brain barrier(BBB) after transient ischemia. Methods Seventeen day pregnant rats were selected. The uterine arteries of the rats were clamped for 30 minutes in experimental group. BDNF labeled with 125 I was injected into the rats through caudal veins. The radioactivity of BDNF in different fetal organs was measured at 24 h, 48 h and 72 h. Results 125 I BDNF was detected in amniotic fluid, placenta and fetal organs including brain, heart, lung, liver and kidney. This indicated that BDNF partly permeated placental barrier. The permeability of BDNF through placenta barrier and fetal BBB increased with the increased dose injected. BDNF reached the fetal brain through BBB under hypoxia eschemia condition. The rates of penetration of BDNF through placental barrier and BBB increased under the condition of fetal ischemia and hypoxia. Conclusions Exogenic BDNF may partly go through placental barrier and BBB into fetal brain, which makes it possible for BDNF to be a treatment for fetus suffered from ischemia and hypoxia.
5.ClinicaI significance of T follicuLar helper cells in rheumatoid arthritis
Yunchun LI ; Zhongjun FANG ; Li ZHONG ; Yue WANG ; Fan YANG ; Xiaoyun JI
International Journal of Laboratory Medicine 2015;(16):2324-2325,2328
Objective To investigate the percentages of T follicuLar helper cells (Tfh)and interleukin-21(IL-21)in the plasma of patients with rheumatoid arthritis,and the immunological mechanism of Tfh cells in the development of rheumatoid arthritis. Methods According to ACR and DAS28,patients with rheumatoid arthritis were divided into low,moderate and high activity group.The percentages of CD3 + CD4 + CXCR+ 、CD3 + CD4 + ICOS+ and CD3 + CD4 + CXCR+ ICOS+ Tfh cells were detected by Flow Cytometry.While the levels of IL-21 、RF-IgM and anti-CCP in plasma were measured by ELlSA test.The analysis was performed by t-test and Spearman′s correlation analysis.Results The expression of CD3 + CD4 + CXCR+ ICOS+ Tfh cells in PBMCs of rheu-matoid arthritis was significantly higher than that in the normal controls(P <0.05).Meanwhile the results of the three rheumatoid arthritis groups(low,moderate and high activity groups)showed that the expression of Tfh increased accordingly(P <0.05).The expression of Tfh in rheumatoid arthritis was positively related with the levels of IL-21 ,ESR,CRP,RF and anti-CCP respectively. Conclusion The expression of Tfh and IL-21 increases significantly and is closely related to the disease activity in rheumatoid ar-thritis.The results indicate that the abnormality of Tfh may play an important role in the pathogenesis of rheumatoid arthritis.
6.Factors accounting for HIV antibody test false positive results in patients with rheumatoid arthritis
Yunchun LI ; Li ZHONG ; Yue WANG ; Fan YANG ; Zhongjun FANG ; Liumei DING
Chinese Journal of Laboratory Medicine 2016;39(7):522-525
Objective To investigate if immunological factors associated with the false HIV screening test results in RA.Methods Subjects who attended the Rheumatology Outpatient Clinic -Internal Medicine Unit of Guanghua Integrative Hospital , from October 2013 to October 2014, who met the American College of Rheumatology /European League Against Rheumatism Criteria for RA were recruited for the study . 100 subjects with RA were recruited.Each patient underwent clinical examination and blood sampling for assessment of serum HIV screening test and Rheumatoid factors ( RF-IgA, -IgG, -IgM) and anti-cyclic citrullinated protein antibodies (anti-CCP) were purified from the plasma and detected by ELISA , Samples were collected and processed using standard protocols and were stored in the same freezer before analysis . RA patients were divided into two groups based on the titters of RF and anti -CCP:RF <18 U/ml/anti-CCP <25 U/ml group and RF >300 U/ml /anti-CCP >500 U/ml group.HIV screening tests were determined by three methods: ELISA、Immuno-colloidal Golden Method and ECLIA.The positive results were confirmed by the Changning Centers for Disease Control , Shanghai through western -blotting test.Results 100 samples detected by ELISA and Immuno-colloidal Golden Method were given negative results , 16 positive results existed in ECLIA group.There were1,12,3 positive cases in RF-IgM <18 U/ml, RF-IgM and RF-IgG >300 U/ml group(2.7%,32.4%,13.6%;P <0.01).In anti-CCP <25 RU/ml and >500 RU/ml groups there were 2 and 4 positive results(4.7%,24.6%;P <0.01).Conclusions Different HIV screening test methods would give different results , according to operation requirement using second method to determine the HIV screening result.HIV False-positivity was associated with the titers of anti -CCP and RF in RA.
7.Experimental research into the inhibitory effect of 131I-recombinant human epidermal growth factor on the growth of breast cancer in vivo.
Yunchun LI ; Weiyun XU ; Tianzhi TAN ; Sheng HE
Journal of Biomedical Engineering 2004;21(3):444-448
This experiment was designed to study the effect of 131I-recombinant human epidermal growth factor (131I-rhEGF) on the growth of tumor in nude mice loaded with human breast cancer. Bioactivity of 131I-rhEGF and uptake of 131I-rhEGF in breast cancer tissue were verified using biodistribution experiment of 131I-rhEGF in the nude mice loaded with human breast cancer. The effect of 131I-rhEGF on the growth of tumor was assessed via the growth experiment of tumor in the nude mice loaded with human breast cancer. The ultrastructural change of the tumor cell treated with 131I-rhEGF was observed under transmission electron microscope, and the pathological change of the tumor tissue treated with 131I-rhEGF was detected by biopsy. The results showed that the tumor tissue of nude mice bearing human breast cancer obviously takes in 131I-rhEGF; that intravenous administration and intratumoral administration of 131I-rhEGF both obviously inhibit the growth of tumor, the inhibition rates (82.00% and 80.70%) being remarkably higher than that of 131I (7.49%) and that of 131I-HSA (6.91%) (P<0.05); and that intravenous and intratumoral administration of 131I-rhEGF both obviously damage and kill tumor cells. Therefore, 131I-rhEGF can inhibit the growth of human breast cancer cell in nude mice; it is a potential receptor-mediated radioactivity targeting drug for treating breast cancer.
Animals
;
Breast Neoplasms
;
pathology
;
ultrastructure
;
Drug Delivery Systems
;
Epidermal Growth Factor
;
biosynthesis
;
genetics
;
pharmacology
;
Female
;
Humans
;
Iodine Radioisotopes
;
administration & dosage
;
pharmacology
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Neoplasm Transplantation
;
Receptor, Epidermal Growth Factor
;
metabolism
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
pharmacology
8.Iodination conditions of KH901, a tumor-specific oncolytic recombinant adenovirus, and its 125I-labeled compounds biodistribution in animals.
Yanxia MI ; Yunchun LI ; Yahong LONG ; Peng XIE
Journal of Biomedical Engineering 2009;26(5):1064-1093
In this research was developed high efficiency method using 125I for directly labeling KH901, a tumor-specific oncolytic recombinant adenovirus, biodistribution of 125I-labeled compound in normal mice was investigated. 125I-KH901 was prepared by N-bromosuccinimide labeling method to find the optimal ratio of labeling response. The compounds were isolated and purified by Sephadex-G10 agarose and the radiochemical purity of compounds was analyzed by paper chromatography. The radioactivity biodistribution in mice was measured at different times after caudal vein injection with 0.1ml 125I-KH901. The labeling yield of 125I-KH901 was 78% and the radiochemical purity was 95% after purification by Sephadex-G10 agarose. Biodistribution revealed that the uptake of 125I-KH901 in liver was higher than in other organs at all time points of the experiment. 125I-KH901 was mainly concentrated in liver, kidneys, spleen and lung. It can be seen that N-bromosuccinimide labeling method is an optimal method with simple steps and high labeling yield in labeling KH901 with 125I. 125I-KH901 has a biodistribution trait which is an advantage to treating liver tumors.
Adenoviridae
;
genetics
;
physiology
;
Animals
;
DNA, Recombinant
;
genetics
;
Female
;
Genetic Vectors
;
genetics
;
Iodine Radioisotopes
;
pharmacokinetics
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Oncolytic Viruses
;
genetics
;
physiology
9.Radiobiological effect of 131I radiolabeled recombinant human epidermal growth factor on nude mice with human breast cancer.
Yunchun LI ; Weiyun XU ; Tianzhi TAN ; Sheng HE
Journal of Biomedical Engineering 2005;22(4):749-753
The radiobiological effect of 131I radiolabeled recombinant human epidermal growth factor (131I-rhEGF) on nude mice with human breast cancer was assessed in this study. The tissue mainly uptaking 131I-rhEGF was found by tissue distribution assay in mice. The radiation breakdown of the tissue greatly collecting 131I-rhEGF was examined by biochemical test and biopsy in nude mice with human breast cancer. The tissue distribution assay of 131I-rhEGF in mice showed that 131I-rhEGF greatly accumulated in kidney, liver, spleen and blood. The biochemical test and biopsy revealed that 131I -rhEGF injected twice (dosing once is analogous to 14.58 GBq in a person with 50 kg, once every 14 days) had an effective killing effect on tumor but had no effect of radiation breakdown on kidney, liver,spleen and blood-cell forming tissue in mice with human breast cancer. Therefore, 131I-rhEGF is a drug unharmful to normal tissues in the course of the receptor-mediated target radiotherapy for breast cancer.
Animals
;
Breast Neoplasms
;
metabolism
;
pathology
;
radiotherapy
;
Cell Line, Tumor
;
Drug Delivery Systems
;
Epidermal Growth Factor
;
biosynthesis
;
genetics
;
pharmacokinetics
;
therapeutic use
;
Humans
;
Iodine Radioisotopes
;
Mice
;
Mice, Nude
;
Neoplasm Transplantation
;
Radiopharmaceuticals
;
Random Allocation
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
pharmacokinetics
;
therapeutic use
10.Antitumor effects of radioiodine labeled KH901 on nude mice bearing hepatoma.
Yanxia MI ; Yunchun LI ; Yahong LONG
Journal of Biomedical Engineering 2010;27(2):389-394
In order to evaluate the biological activity in vitro and the antitumor effects of 131I-conditionally replicating oncolytic adenovirus KH901 on HepG2 human hepatoma xenografts, the leves of GM-CSF expression were determined by ELISA method. A panel of tumor and normal cells was infected with recombinant adenovirus KH901 at MOI of 10 PPC. The medium was harvested to determine the bioactivity of GM-CSF after 24 hours. Nude mice bearing HepG2 human hepatoma xenografts were given 131-KH901. Antitumor effects were assessed using endpoints of tumor growth delay. The data showed that after 24 hours 131-KH901 replicated hugely in tumor cells and produced significant amount of GM-CSF 183.27 +/- 6.90 pg/ml, while producing very small amount of GM-CSF 20.44 +/- 0.77 pg/ml in normal cells. In the treatment of tumor, 131I-KH901 showed higher restraint rate (71.3%) compared to 131I (22.7%) or KH901 (52.7%). Therefore, 131-KH901 can inhibit the growth of human hepatoma cell in nude mice and it may be a potential drug for treating liver cancer.
Adenoviridae
;
genetics
;
metabolism
;
Animals
;
Female
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
genetics
;
metabolism
;
Hep G2 Cells
;
Humans
;
Iodine Radioisotopes
;
Liver Neoplasms, Experimental
;
diagnostic imaging
;
pathology
;
virology
;
Male
;
Mice
;
Mice, Nude
;
Oncolytic Virotherapy
;
Oncolytic Viruses
;
genetics
;
metabolism
;
Radionuclide Imaging